CHEBI:747481 - lorecivivint

ChEBI IDCHEBI:747481
ChEBI Namelorecivivint
Stars
DefinitionA CDC-like kinase/dual-specificity tyrosine kinase (CLK/DYRK) inhibitor being developed as a potential intra-articular knee osteoarthritis (OA) treatment.
Last Modified2 April 2026
SubmitterAnneNiknejad
DownloadsMolfile
FormulaC29H24FN7O
Net Charge0
Average Mass505.557
Monoisotopic Mass505.20264
SMILESCC(C)CC(=O)Nc1cncc(-c2ccc3nnc(-c4nc5cncc(-c6cccc(F)c6)c5n4)c3c2)c1
InChIInChI=1S/C29H24FN7O/c1-16(2)8-26(38)33-21-10-19(12-31-13-21)17-6-7-24-22(11-17)28(37-36-24)29-34-25-15-32-14-23(27(25)35-29)18-4-3-5-20(30)9-18/h3-7,9-16H,8H2,1-2H3,(H,33,38)(H,34,35)(H,36,37)
InChIKeyAQDWDWAYVBQMAM-UHFFFAOYSA-N
ChEBI Ontology
Outgoing Relation(s)
lorecivivint (CHEBI:747481) is a organic molecular entity (CHEBI:50860)
Manual XrefsDatabases
D11588KEGG DRUG